0000899243-23-004063.txt : 20230206
0000899243-23-004063.hdr.sgml : 20230206
20230206171826
ACCESSION NUMBER: 0000899243-23-004063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230202
FILED AS OF DATE: 20230206
DATE AS OF CHANGE: 20230206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOUTHWELL DAVID P
CENTRAL INDEX KEY: 0001251553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 23591576
MAIL ADDRESS:
STREET 1: C/O INOTEK PHARMACEUTICALS CORPORATION
STREET 2: 91 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TScan Therapeutics, Inc.
CENTRAL INDEX KEY: 0001783328
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825282075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857-399-9500
MAIL ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-02
0
0001783328
TScan Therapeutics, Inc.
TCRX
0001251553
SOUTHWELL DAVID P
C/O TSCAN THERAPEUTICS, INC.
830 WINTER STREET
WALTHAM,
MA
02451
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
1.81
2023-02-02
4
A
0
100000
0.00
A
2033-02-01
Voting Common Stock
100000
100000
D
The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.
/s/ David P. Southwell
2023-02-06